SCHEMBL16080106

SCHEMBL16080106

O=C1OC(c2ccccc2)=C/C1=C/c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.62
KMT2A Q03164 10/20 0.62
MEN1 O00255 9/20 0.62
KDM4E B2RXH2 4/20 0.62
TDP1 Q9NUW8 2/20 0.62
ALDH1A1 P00352 9/20 0.60
POLB P06746 3/20 0.60
PKM P14618 3/20 0.60
ALOX12 P18054 2/20 0.60
NPSR1 Q6W5P4 1/20 0.60
HSD17B10 Q99714 1/20 0.60
SMN1; SMN2 Q16637 5/20 0.57
RAB9A P51151 3/20 0.57
NPC1 O15118 2/20 0.57
HTT P42858 2/20 0.57
HPGD P15428 2/20 0.57
GAA P10253 1/20 0.57
LMNA P02545 2/20 0.54
RECQL P46063 1/20 0.52
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24345234 0.85 MAPT (0.73) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL1753097 0.85 MAPT (0.73) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10578610 0.84 MAPT (0.54) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10578612 0.84 MAPT (0.54) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL14571475 0.83 KMT2A (0.55) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10575626 0.82 MAPT (0.59) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10575636 0.82 MAPT (0.59) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL9300939 0.81 KMT2A (0.69) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL5803667 0.79 MAPT (0.47) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10576236 0.78 MAPT (0.55) MAPTKMT2AMEN1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9812263-B2 Compound and photoelectric conversion device ADEKA CORPORATION (JP) 2017-11-07 US disclosed
US-9805879-B2 Dye-sensitized solar cell ADEKA CORPORATION (JP) 2017-10-31 US disclosed
US-9805879-B2 Dye-sensitized solar cell ADEKA CORPORATION (JP) 2017-10-31 US disclosed
US-9530571-B2 Compound and support material supporting this novel compound ADEKA CORPORATION (JP) 2016-12-27 US disclosed
US-20160211085-A1 NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE ADEKA CORPORATION (JP) 2016-07-21 US disclosed
US-9324889-B2 Compound and photoelectric conversion device ADEKA CORPORATION (JP) 2016-04-26 US disclosed
US-20150380171-A1 CARRIER SYSTEM AND PHOTOELECTRIC CONVERSION DEVICE ADEKA CORPORATION (JP) 2015-12-31 US disclosed
US-20140299191-A1 DYE-SENSITIZED SOLAR CELL ADEKA CORPORATION (JP) 2014-10-09 US disclosed
US-20140261647-A1 NOVEL COMPOUND AND SUPPORT MATERIAL SUPPORTING THIS NOVEL COMPOUND ADEKA CORPORATION (JP) 2014-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160211085-A1 NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE CYP1B1, PAH, CRY1 MAPT 4548/4885KMT2A 1962/4885MEN1 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.